Evidence map›Paper›PMID 27095865›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Thyrotropinoma with Graves' disease detected by the fusion of indium-111 octreotide scintigraphy and pituitary magnetic resonance imaging.

Kursat Okuyucu, Engin Alagoz, Nuri Arslan, Abdullah Taslipinar, Mehmet Salih Deveci, Erol Bolu

Abstract readCase Reports
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kursat OkuyucuDepartment of Nuclear Medicine, Gulhane Military Medical Academy, Ankara, Turkey.
Engin AlagozDepartment of Nuclear Medicine, Gulhane Military Medical Academy, Ankara, Turkey.
Nuri ArslanDepartment of Nuclear Medicine, Gulhane Military Medical Academy, Ankara, Turkey.
Abdullah TaslipinarDepartment of Endocrinology, Gulhane Military Medical Academy, Ankara, Turkey.
Mehmet Salih DeveciDepartment of Pathology, Gulhane Military Medical Academy, Ankara, Turkey.
Erol BoluDepartment of Endocrinology, Gulhane Military Medical Academy, Ankara, Turkey.
Turkish Armed Forces · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid-stimulating hormone-secreting pituitary adenoma (TSHoma) is a rare benign endocrinological tumor which produces TSH in the pituitary gland. Herein, we presented a female patient having TSHoma with Graves' disease during and just after pregnancy that we found by indium-111 octreotide scintigraphy while investigating the patient for hyperthyroidism symptoms.

Indexed as

Graves’ diseaseindium-111 octreotide scintigraphythyroid-stimulating hormone-secreting pituitary adenoma

Identifiers

PMID27095865
PMCPMC4815389
OpenAlexW2295006657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.